Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Amortization of Deferred Charges (2018 - 2025)

Orthofix Medical (OFIX) has disclosed Amortization of Deferred Charges for 13 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortization of Deferred Charges fell 82.52% year-over-year to $2.0 million, compared with a TTM value of $5.9 million through Dec 2025, down 62.68%, and an annual FY2025 reading of $5.9 million, down 62.68% over the prior year.
  • Amortization of Deferred Charges was $2.0 million for Q4 2025 at Orthofix Medical, up from $1.6 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $11.3 million in Q4 2024 and bottomed at $735000.0 in Q4 2022.
  • Average Amortization of Deferred Charges over 5 years is $1.8 million, with a median of $1.2 million recorded in 2023.
  • The sharpest move saw Amortization of Deferred Charges surged 307.07% in 2023, then tumbled 82.52% in 2025.
  • Year by year, Amortization of Deferred Charges stood at $851000.0 in 2021, then decreased by 13.63% to $735000.0 in 2022, then soared by 307.07% to $3.0 million in 2023, then surged by 277.67% to $11.3 million in 2024, then crashed by 82.52% to $2.0 million in 2025.
  • Business Quant data shows Amortization of Deferred Charges for OFIX at $2.0 million in Q4 2025, $1.6 million in Q3 2025, and $1.1 million in Q2 2025.